Xuefuzhuyu decoction combined with retinal laser photocoagulation in the treatment of retinal vein occlusion
Xian-yong Cao,Li Sun,Xiao-qian Zhu,Qun Fu
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.47.005
2006-01-01
Abstract:AIM: To observe the curative effect of Xuefuzhuyu decoction combined with the retinal laser photocoagulation in treatment of patients with retinal vein occlusion (RVO). METHODS: ① Seventy-four patients (74 eyes) with RVO, who were 25-76 years old with an mean age of 62 years and a course of disease ranged from 5 days to 3 years, were selected from the Department of Ophthalmology, Third Hospital Affiliated to Xinxiang Medical College between April 2004 and June 2006, including 9 eyes in patients with the course of disease less than 15 days, 41 eyes in patients with the course of disease ranged from 15 days to 3 months, 7 eyes in patients with the course of disease ranged from 3 months to 6 months, 4 eyes in patients with the course of disease ranged from 6 months to 12 months, 6 eyes in patients with the course of disease ranged from 12 months to 18 months, 5 eyes in patients with the course of disease ranged from 18 months to 24 months and 2 eyes in patients with the course of disease ranged from 24 months to 36 months. ② Based on retinal laser photocoagulation, patients orally took Xuefuzhuyu decoction (9 g of Danggui, 9 g of Shengdi, 9 g of Niuxi, 9 g of Honghua, 12 g of Taoren, 6 g of Caihu, 6 g of Jike, 6 g of Jugeng and 3 g of Gancao, one dose a day and twice a day) to observe the clinical effects. ③ Therapeutic criteria: Healed as complete absorption of retinal hemorrhage (RH) and edema, and the sight was enhanced more than 4 rows or recover to the level as before; retinal fluorescein angiography showed that no perfusion disappeared in blood capillaries, and newly born capillaries extinction and fibrosis were detected without vessel leakage or macular edema. Valid: Most of RH was absorbed with an enhancement of 3-4 rows in sight, and retinal fluorescein angiography showed that most of retinal circulation was ameliorated. Improved: The sight was enhanced less than one row or decreased without significant improvement in eye ground, and no changes in retinal fluorescein angiography. RESULTS: A follow-up of 2-9 months was done in 74 patients. ① 39 patients (53%) healed, including 6 patients with the course of disease less than 15 days, 27 patients between 15 days and e months, 4 patients between 3 months and 6 months, 2 patients between 6 months and 12 months. ② 14 patients (19%) got valid effect, including 3 patients with the course of disease less than 15 days, 8 patients between 15 days and 3 months, one patient between 3 months and 6 months, 2 patients between 6 months and 18 months. ③ 13 patients (18%) turned better, including 6 patients with the course of disease between 15 days and 3 months, one patient between 3 months and 6 months, one patient between 6 months and 12 months, 2 patients between 12 months and 18 months, 3 patients between 18 months and 24 months. ④ It was invalid in 8 patients (11%), including one patient with the course of disease ranged from 15 days to 6 months, one patient ranged from 6 months to 12 months, 2 patients ranged from 12 months to 18 months, 2 patients from 18 months to 24 months, 2 patients from 24 months to 36 months with a total effective rate of 89%. No patient whose course of disease above one year healed, and all patients whose course of disease below 3 months healed. CONCLUSION: The effect of Xuefuzhuyu decoction combined with retinal laser photocoagulation on patients with RVO is excellent, and the shorter the course of disease is, the better the effect is